Concepedia

Ashok Kumar Jayavelu

AK

Statistics

Publications

21

Citations

885

H-Index

15

Active since

2004

Affiliations

Max Planck Institute of Biochemistry(Current)

Heidelberg University

German Cancer Research Center

Jena University Hospital

Harvard University

Ashok Kumar Jayavelu is an author at Max Planck Institute of Biochemistry specializing in molecular oncology, oncology, and molecular biology.

Publications per year

2004–2025

21

Publications

21

Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms

Ashok Kumar Jayavelu, Tina M. Schnöder, Florian Perner et al. · Nature · 2020 · 156 citations

Veterinary Medicine, Molecular Biology, Oncology +13

The proteogenomic subtypes of acute myeloid leukemia

Ashok Kumar Jayavelu, Sebastian Wolf, Florian Buettner et al. · Cancer Cell · 2022 · 147 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

A Cell-Autonomous Signature of Dysregulated Protein Phosphorylation Underlies Muscle Insulin Resistance in Type 2 Diabetes

Thiago M. Batista, Ashok Kumar Jayavelu, Nicolai J. Wewer Albrechtsen et al. · Cell Metabolism · 2020 · 107 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells

Ashok Kumar Jayavelu, Jörg P. Müller, Reinhard Bauer et al. · Leukemia · 2015 · 66 citations

Life Sciences, Cancer Biology, Molecular Biology +14

YBX1 mediates translation of oncogenic transcripts to control cell competition in AML

Florian Perner, Tina M. Schnoeder, Yijun Xiong et al. · Leukemia · 2021 · 63 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 21